BIOTON S.A. (WSE:BIO)
Poland flag Poland · Delayed Price · Currency is PLN
4.070
-0.050 (-1.21%)
Jul 25, 2025, 4:36 PM CET

BIOTON Company Description

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles.

BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

BIOTON S.A.
CountryPoland
Founded1989
IndustryBiotechnology
SectorHealthcare
Employees364
CEOJeremy Launders

Contact Details

Address:
ul. Poznanska 12
Ozarów Mazowiecki, 05-850
Poland
Phone48 22 721 4000
Websitebioton.pl

Stock Details

Ticker SymbolBIO
ExchangeWarsaw Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyPLN
ISIN NumberPLBIOTN00029
SIC Code2834

Key Executives

NamePosition
Mateusz Patryk KoseckiHead of Biolek Business Unit and Chief Executive Officer of Biolek Sp. Z O.O.
Artur Mroz-GoncalvesChief Executive Officer and Sales and Marketing Director at Bioton Marketing Agency (BMA)
Jeremy LaundersChief Executive Officer and President of the Management Board
Adam Tomasz PolonekMember of Management Board
Anna GrabowskaSenior Finance Manager
Michal DeptuchOperations Director
Renata ProkopczykChief Accountant
Dariusz GurtowskiDirector of Science and Technology
Kamila MusnickaDirector of Legal Department
Ewelina RomanskaDirector of Human Resources and Communication